Credits Available: 3.50 AMA PRA Category 1 Credit

Description: Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments may help patients live longer, creating unique clinical needs. Adults now make up more than a quarter of patients with SMA. However, there are no specific guidelines for the assessment and treatment of adult patients, leading to gaps in their diagnosis and management. Adult care is complex and requires multidisciplinary care. This collaborative CME provides the opportunity to learn and share best practices that will improve outcomes for patients with SMA.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, MBBS, Nurse Practitioner, Nurse, Physician Assistant, Social Worker, Physical Therapist, Pharmacist, Healthcare Navigator
Target Specialties: Neurology, Pulmonary/Respiratory Physician, Physiatry/Rehabilitation, Genetics/Genomics, Orthopedic Medicine/Sports Medicine, Pharmacy, Nutrition, Pediatrics

Yasir Jassam

Pickup family Neuroscience Institute
Director of Multiple Aclerosis and Neuroimmunology program, Chair of the Dept. of Neurology and Psychiatry

Yasir Jassam, MD, MRCP(UK) FRCP (Glasg) FRCP(London) FAAN, is a neurologist and a neuroimmunologist.
After graduating from medical school, he received post graduate training in both internal medicine and neurology. He completed Core Medical Training (CMT) in Cambridge University Hospitals in the United Kingdom (UK), he also earned the Membership of the Royal College of Physicians of the UK and a diploma in neuroimaging for research from the University of Edinburgh.
After moving to the U.S, Dr. Jassam completed neurology residency training in Tufts University in Boston, MA where he also served as a chief resident in neurology.
He then trained as a clinical fellow in neuroimmunology at the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH).
Dr. Jassam is board-certified by the American Board of Psychiatry and Neurology (ABPN). Dr. Jassam held the position of an assistant professor of neurology and attending neurologist and neuroimmunologist in Kansas University Medical Center before joining Hoag memorial hospital Presbyterian in March 2021 where he currently serves as the director of the Multiple sclerosis and Neuroimmunology program and the vice chair of the department of neurology and psychiatry.
He is an elected Fellow of the Royal College of Physicians and Surgeons of Glasgow, the Royal College of Physicians of London, and the American Academy of Neurology (AAN).
His focus of specialty includes autoimmune neurological and neuroinflammatory disorders such as Multiple sclerosis, Neuromyelitis Optica (NMO), autoimmune encephalitis, transverse myelitis, optic neuritis, CNS vasculitis, neuro-sarcoidosis and others. He also has interest in medical myelopathies and non-surgical disorders of the spinal cord.